DE3675408D1 - Phenylcarbamate. - Google Patents
Phenylcarbamate.Info
- Publication number
- DE3675408D1 DE3675408D1 DE8686102812T DE3675408T DE3675408D1 DE 3675408 D1 DE3675408 D1 DE 3675408D1 DE 8686102812 T DE8686102812 T DE 8686102812T DE 3675408 T DE3675408 T DE 3675408T DE 3675408 D1 DE3675408 D1 DE 3675408D1
- Authority
- DE
- Germany
- Prior art keywords
- sub
- phenylcarbamate
- pharmaceuticals
- useful
- phenyl carbamates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C333/14—Dithiocarbamic acids; Derivatives thereof
- C07C333/30—Dithiocarbamic acids; Derivatives thereof having sulfur atoms of dithiocarbamic groups bound to other sulfur atoms
- C07C333/32—Thiuramsulfides; Thiurampolysulfides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL74497A IL74497A (en) | 1985-03-05 | 1985-03-05 | Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3675408D1 true DE3675408D1 (de) | 1990-12-13 |
Family
ID=11055728
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE1998175046 Pending DE19875046I1 (de) | 1985-03-05 | 1986-03-04 | Phenylcarbamate |
DE8686102812T Expired - Lifetime DE3675408D1 (de) | 1985-03-05 | 1986-03-04 | Phenylcarbamate. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE1998175046 Pending DE19875046I1 (de) | 1985-03-05 | 1986-03-04 | Phenylcarbamate |
Country Status (25)
Country | Link |
---|---|
US (1) | US4948807A (de) |
EP (1) | EP0193926B3 (de) |
JP (1) | JPS61225158A (de) |
KR (1) | KR940010764B1 (de) |
AT (1) | ATE58130T1 (de) |
AU (1) | AU595504B2 (de) |
CA (1) | CA1284501C (de) |
CY (2) | CY1748A (de) |
DE (2) | DE19875046I1 (de) |
DK (1) | DK172851B1 (de) |
ES (1) | ES8801193A1 (de) |
FI (1) | FI87197C (de) |
GR (1) | GR860586B (de) |
HK (1) | HK130293A (de) |
HU (1) | HU201297B (de) |
IE (1) | IE58838B1 (de) |
IL (1) | IL74497A (de) |
LU (1) | LU90312I2 (de) |
MY (1) | MY137602A (de) |
NL (1) | NL980031I2 (de) |
NZ (1) | NZ215348A (de) |
PH (1) | PH23325A (de) |
PL (1) | PL146301B1 (de) |
PT (1) | PT82127B (de) |
ZA (1) | ZA861653B (de) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH667001A5 (de) * | 1985-09-03 | 1988-09-15 | Hugo Degen | Untermatratze. |
HU201906B (en) * | 1987-03-04 | 1991-01-28 | Sandoz Ag | Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them |
DE3805744C2 (de) * | 1987-03-04 | 1999-09-23 | Novartis Ag | Phenylcarbamate zur Hemmung der Acetylcholinesterase |
US5091583A (en) * | 1990-05-07 | 1992-02-25 | Air Products And Chemicals, Inc. | Tertiary amine catalysts for polurethanes |
IT1271679B (it) * | 1994-07-18 | 1997-06-04 | Mediolanum Farmaceutici Srl | Derivati del fenilcarbammato atti all'impiego come anticolinesterasici |
US20100210590A1 (en) * | 1995-09-27 | 2010-08-19 | Northwestern University | Compositions and treatments for seizure-related disorders |
US5965571A (en) * | 1996-08-22 | 1999-10-12 | New York University | Cholinesterase inhibitors for treatment of Parkinson's disease |
EP1535902B1 (de) | 1996-12-18 | 2007-11-07 | Teva Pharmaceutical Industries, Ltd. | Aminoindanderivate |
DK0951284T3 (da) * | 1996-12-18 | 2004-02-16 | Teva Pharma | Phenylethylminderivater |
US6251938B1 (en) | 1996-12-18 | 2001-06-26 | Teva Pharmaceutical Industries, Ltd., | Phenylethylamine derivatives |
WO1998031356A1 (en) * | 1997-01-17 | 1998-07-23 | Takeda Chemical Industries, Ltd. | Idebenone containing combination agent for treating alzheimer's disease |
US5962535A (en) * | 1997-01-17 | 1999-10-05 | Takeda Chemical Industries, Ltd. | Composition for alzheimer's disease |
GB9716879D0 (en) * | 1997-08-08 | 1997-10-15 | Shire Int Licensing Bv | Treatment of attention deficit disorders |
US6316023B1 (en) * | 1998-01-12 | 2001-11-13 | Novartis Ag | TTS containing an antioxidant |
EP1133230A4 (de) * | 1998-11-23 | 2004-05-26 | Bonnie M Davis | Dosisformulierungen für acetylcholinesterase-inhibitoren |
GB9923045D0 (en) * | 1999-09-29 | 1999-12-01 | Novartis Ag | New oral formulations |
US6534541B1 (en) * | 1999-10-19 | 2003-03-18 | Novartis Ag | Treatment of ocular disorders |
KR20090064603A (ko) | 2000-01-28 | 2009-06-19 | 마텍 바이오싸이언스스 코포레이션 | 발효기 내에서 진핵 미생물의 고밀도 배양에 의한 고도불포화 지방산을 함유하는 지질의 증진된 생산 방법 |
EP1311272B1 (de) * | 2000-03-03 | 2006-11-22 | Eisai Co., Ltd. | Neue methoden unter verwendung von cholinesteraseinhibitoren |
US20030153598A1 (en) * | 2000-07-25 | 2003-08-14 | Raymond Pratt | Methods for treating Parkinson's disease with cholinesterase inhibitors |
AU2001257022B2 (en) * | 2000-04-13 | 2005-02-03 | Mayo Foundation For Medical Education And Research | Abeta 42 lowering agents |
GB0126378D0 (en) * | 2001-11-02 | 2002-01-02 | Oxford Biomedica Ltd | Antigen |
US20040010038A1 (en) * | 2002-02-27 | 2004-01-15 | Eran Blaugrund | Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors |
WO2003101917A2 (en) * | 2002-05-31 | 2003-12-11 | Sun Pharmaceutical Industries Limited | A process for the preparation of phenylcarbamates |
SI2389937T1 (sl) | 2002-06-14 | 2018-10-30 | Toyama Chemical Co., Ltd, | Farmacevtska sestava za izboljšanje možganske funkcije |
EA010267B1 (ru) | 2002-10-07 | 2008-06-30 | Те Риджентс Оф Те Юниверсити Оф Калифорния | Модуляция тревоги через блокаду гидролиза анандамида |
CZ293014B6 (cs) * | 2002-10-24 | 2004-01-14 | Léčiva, A.S. | Způsob výroby (-)-(S)-3-[1-(dimethylamino)ethyl]fenyl-N-ethyl-N-methylkarbamátu |
DE10301851A1 (de) * | 2003-01-17 | 2004-07-29 | Lts Lohmann Therapie-Systeme Ag | Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel |
EP1603548A4 (de) * | 2003-02-05 | 2007-10-10 | Myriad Genetics Inc | Verfahren und zusammensetzung zur behandlung neurodegenerativer erkrankungen |
US7521481B2 (en) * | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
CA2532207A1 (en) * | 2003-07-11 | 2005-07-21 | Myriad Genetics, Inc. | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease |
WO2005042475A2 (en) * | 2003-10-21 | 2005-05-12 | Sention, Inc. | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
ES2347152T3 (es) | 2003-11-26 | 2010-10-26 | Pfizer Products Inc. | Derivados de aminopirazol como inhibidores de gsk-3. |
GB0329284D0 (en) * | 2003-12-18 | 2004-01-21 | Avecia Ltd | Process |
GB2409453A (en) | 2003-12-24 | 2005-06-29 | Generics | Process for the preparation of aminoalkyl phenylcarbamates |
US20050222123A1 (en) | 2004-01-27 | 2005-10-06 | North Shore-Long Island Jewish Research Institute | Cholinesterase inhibitors for treating inflammation |
WO2006001877A2 (en) * | 2004-04-13 | 2006-01-05 | Myriad Genetics, Inc. | Combination treatment for neurodegenerative disorders comprising r-flurbiprofen |
WO2006020850A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
BRPI0514303A (pt) * | 2004-08-11 | 2008-06-10 | Myriad Genetics Inc | composição farmacêutica e método para tratar distúrbios neurodegenerativos |
WO2006020852A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
WO2006050359A2 (en) * | 2004-11-02 | 2006-05-11 | Northwestern University | Pyridazine compounds and methods |
ES2615487T3 (es) * | 2004-11-08 | 2017-06-07 | Emcure Pharmaceuticals Limited | un método eficaz para la preparación de (S)-3-[(1-dimetilamino)etil]-fenil-N-etil-N-metil-carbamato |
US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
KR20070084455A (ko) * | 2004-11-23 | 2007-08-24 | 워너-램버트 캄파니 엘엘씨 | 지질혈증 치료용 hmg co-a 환원효소 억제제로서의7-(2h-피라졸-3-일)-3,5-디히드록시-헵탄산 유도체 |
DE602006016934D1 (de) | 2005-04-06 | 2010-10-28 | Adamas Pharmaceuticals Inc | Verfahren und zusammensetzungen zur behandlung von zns-erkrankungen |
US20070015832A1 (en) * | 2005-07-14 | 2007-01-18 | Myriad Genetics, Incorporated | Methods of treating overactive bladder and urinary incontinence |
ES2267399B1 (es) | 2005-08-04 | 2008-02-01 | Ragactives, S.L. | Procedimiento para la obtencion de carbamatos de fenilo. |
EP1956904B1 (de) * | 2005-12-09 | 2017-04-12 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Niedrig dosierter ladostigil zur behandlung von leichter kognitiver beeinträchtigung |
TW200744576A (en) * | 2006-02-24 | 2007-12-16 | Teva Pharma | Propargylated aminoindans, processes for preparation, and uses thereof |
US7767843B2 (en) | 2006-03-02 | 2010-08-03 | Apotex Pharmachem Inc. | Process for the preparation of phenylcarbamates |
EP2015750A2 (de) * | 2006-04-28 | 2009-01-21 | Northwestern University | Zusammensetzungen und behandlungen mit pyridazinverbindungen und cholisterinasehemmern |
US20080033045A1 (en) * | 2006-07-07 | 2008-02-07 | Myriad Genetics, Incorporated | Treatment of psychiatric disorders |
CA2661009A1 (en) * | 2006-08-17 | 2008-02-21 | Alembic Limited | Improved process for the preparation of rivastigmine |
WO2008037433A1 (en) | 2006-09-29 | 2008-04-03 | Synthon B.V. | Process for making aminoalkylphenyl carbamates and intermediates therefor |
BRPI0718437A2 (pt) | 2006-10-27 | 2013-11-19 | Medivation Neurology Inc | Métodos e terapias de combinação para tratar a doença de alzheimer usando, entre outros, dimebon e dolepezil |
CA2677241A1 (en) | 2007-02-02 | 2008-08-14 | Colucid Pharmaceuticals, Inc. | Compounds that inhibit cholinesterase |
EP1980552A3 (de) | 2007-04-10 | 2008-10-29 | Dr. Reddy's Laboratories Ltd. | Verfahren zur Herstellung von Rivastigmin oder einem Salz daraus |
WO2008124969A1 (fr) * | 2007-04-16 | 2008-10-23 | Topharman Shanghai Co., Ltd. | Méthode de préparation de rivastigmine et de ses intermédiaires |
US7884121B2 (en) | 2007-06-11 | 2011-02-08 | Apotex Pharmachem Inc. | Process for the preparation of phenylcarbamates |
US20090048229A1 (en) * | 2007-07-18 | 2009-02-19 | Rupniak Nadia M J | Methods for promoting wakefulness |
US8593728B2 (en) * | 2009-02-19 | 2013-11-26 | Toyota Motor Engineering & Manufacturing North America, Inc. | Multilayer photonic structures |
EP2349976B1 (de) | 2008-08-25 | 2012-12-26 | Jubilant Life Sciences Limited | Verfahren zur herstellung von (s)-3-[(1-dimethylamino)ethyl]phenyl-n-ethyl-n- methylcarbamat über neue zwischenprodukte |
US8247405B2 (en) | 2008-12-10 | 2012-08-21 | Conopco, Inc. | Skin lightening compositions with acetylcholinesterase inhibitors |
CN101580482B (zh) * | 2009-05-27 | 2014-04-23 | 沈阳药科大学 | 一种重酒石酸盐卡巴拉汀的制备方法和应用 |
ES2363395B1 (es) * | 2010-01-20 | 2012-02-23 | Farmalider, S.A. | Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral. |
CN102134206B (zh) * | 2010-01-27 | 2013-11-20 | 上海京新生物医药有限公司 | 一种卡巴拉汀的制备方法 |
EP2533645B1 (de) | 2010-02-09 | 2016-07-27 | The Johns Hopkins University | Verfahren und zusammensetzungen zur verbesserung von kognitiven funktionen |
WO2011151669A1 (en) | 2010-06-02 | 2011-12-08 | Jubilant Life Sciences Limited | Process for producing enantiomerically enriched isomer of 3-(1-aminoethyl) phenyl derivative and employing the same to produce rivastigmine or its pharmaceutically acceptable salt |
WO2011151359A1 (en) | 2010-06-02 | 2011-12-08 | Noscira, S.A. | Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative |
DK2582799T3 (en) | 2010-06-17 | 2018-02-12 | Codexis Inc | BIOCATALATORS AND PROCEDURES FOR THE SYNTHESIS OF (S) -3- (1-AMINOETHYL) -PHENOL |
WO2012131699A1 (en) | 2011-03-30 | 2012-10-04 | Neon Laboratories Ltd. | Process for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate |
CN102786441B (zh) * | 2011-05-18 | 2013-11-13 | 浙江海正药业股份有限公司 | 利凡斯的明的制备方法、其中间体以及中间体的制备方法 |
RU2014145682A (ru) | 2012-04-14 | 2016-06-10 | Интра-Селлулар Терапиз, Инк | Органические соединения |
ES2449215B1 (es) * | 2012-09-17 | 2014-07-14 | Galenicum Health S.L. | Solución oral de (S)-3-[1-(dimetilamino)etil]fenil N-etil-N-metilcarbamato |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
EP2968220B1 (de) | 2013-03-15 | 2021-05-05 | Agenebio, Inc. | Verfahren und zusammensetzungen zur verbesserung von kognitiven funktionen |
US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
US10357486B2 (en) | 2013-08-16 | 2019-07-23 | Universiteit Maastricht | Treatment of cognitive impairment with PDE4 inhibitor |
US10925834B2 (en) | 2015-05-22 | 2021-02-23 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
KR20200035359A (ko) | 2018-09-26 | 2020-04-03 | 캐딜라 파마슈티클즈 리미티드 | 리바스티그민 제조용 중간체의 합성 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1905990A (en) * | 1931-01-02 | 1933-04-25 | Hoffmann La Roche | Disubstituted carbamic acid esters of phenols containing a basic constituent |
US2208485A (en) * | 1937-04-24 | 1940-07-16 | Hoffmann La Roche | Process for the manufacture of disubstituted carbamic acid esters of phenols containing a basic substituent |
US2362508A (en) * | 1940-12-06 | 1944-11-14 | Merck & Co Inc | Therapeutic substances |
US2493710A (en) * | 1947-03-21 | 1950-01-03 | Hoffmann La Roche | Carbamic acid esters |
DE1037753B (de) * | 1956-07-13 | 1958-08-28 | Rohm & Haas | Schaedlingsbekaempfungsmittel |
-
1985
- 1985-03-05 IL IL74497A patent/IL74497A/xx not_active IP Right Cessation
-
1986
- 1986-02-28 PH PH33465A patent/PH23325A/en unknown
- 1986-03-03 GR GR860586A patent/GR860586B/el unknown
- 1986-03-03 HU HU86870A patent/HU201297B/hu unknown
- 1986-03-03 IE IE55886A patent/IE58838B1/en not_active IP Right Cessation
- 1986-03-03 NZ NZ215348A patent/NZ215348A/en unknown
- 1986-03-03 PT PT82127A patent/PT82127B/pt unknown
- 1986-03-04 JP JP61048183A patent/JPS61225158A/ja active Granted
- 1986-03-04 KR KR1019860001491A patent/KR940010764B1/ko not_active IP Right Cessation
- 1986-03-04 PL PL1986258224A patent/PL146301B1/pl unknown
- 1986-03-04 ES ES552627A patent/ES8801193A1/es not_active Expired
- 1986-03-04 DK DK198600991A patent/DK172851B1/da not_active IP Right Cessation
- 1986-03-04 DE DE1998175046 patent/DE19875046I1/de active Pending
- 1986-03-04 DE DE8686102812T patent/DE3675408D1/de not_active Expired - Lifetime
- 1986-03-04 FI FI860914A patent/FI87197C/fi not_active IP Right Cessation
- 1986-03-04 AT AT86102812T patent/ATE58130T1/de active
- 1986-03-04 EP EP86102812A patent/EP0193926B3/de not_active Expired - Lifetime
- 1986-03-05 ZA ZA861653A patent/ZA861653B/xx unknown
- 1986-03-05 CA CA000503306A patent/CA1284501C/en not_active Expired - Lifetime
- 1986-03-05 AU AU54284/86A patent/AU595504B2/en not_active Expired
-
1987
- 1987-09-25 MY MYPI87003119A patent/MY137602A/en unknown
-
1989
- 1989-03-08 US US07/320,700 patent/US4948807A/en not_active Expired - Lifetime
-
1993
- 1993-11-25 HK HK1302/93A patent/HK130293A/xx not_active IP Right Cessation
-
1994
- 1994-06-03 CY CY174894A patent/CY1748A/xx unknown
-
1998
- 1998-11-04 LU LU90312C patent/LU90312I2/xx unknown
- 1998-11-05 NL NL980031C patent/NL980031I2/nl unknown
-
2004
- 2004-10-27 CY CY200400004C patent/CY2004004I2/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE19875046I1 (de) | Phenylcarbamate | |
FI872335A0 (fi) | Bioreaktor. | |
DE3583779D1 (de) | Gelzusammensetzungen von liposomen. | |
DE3681468D1 (de) | Staubfreie koernige enzymzusammensetzung. | |
DE3583852D1 (de) | Naehrstoffzusammensetzungen. | |
ATE38211T1 (de) | Herstellung von zeolith-l. | |
DE3770889D1 (de) | Herstellung von kubischem bornitrid. | |
DE3671902D1 (de) | Haertbare zusammensetzung. | |
DE3581238D1 (de) | Mikrobiologische herstellung von l-phenylalanin. | |
DE3670063D1 (de) | Herstellung von thioantimonaten. | |
DE3650009T2 (de) | Härtbare Zusammensetzung. | |
IT8720012A0 (it) | Composizione anticorrosione. | |
DE3578163D1 (de) | Herstellung von terpinen-4-olen. | |
DE3676116D1 (de) | Herstellung von azetidin-derivaten. | |
SU1162191A1 (ru) | 1,1-Этилиденди-(5-бром-2-фуроиламин), проявляющий противовоспалительную активность | |
KR880002128U (ko) | 휴대용 사무구 | |
ATE33492T1 (de) | Herstellung von hoeheren arylestern. | |
ATE62471T1 (de) | Herstellung von hydroxyaraldehyden. | |
ATE51604T1 (de) | Herstellung von thioantimonaten. | |
ATE58368T1 (de) | Herstellung von arylestern. | |
DE3762851D1 (de) | Herstellung von spirobiindanbisphenolbischloroformiat-zusammensetzungen. | |
SU1489139A1 (ru) | 3-Изобутил-1-(4-тиоцианатофенил)-5-фенил-Δ-пиразолин, проявляющий противовоспалительную активность | |
FI874288A (fi) | Anordning foer upphoejning av taket pao ett lastutrymme i ett lastfordon. | |
ATE53598T1 (de) | Haertbare zusammensetzung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
V448 | Application of spc |
Free format text: PRODUCT NAME: RIVASTIGMIN (EXELON); REGISTRATION NO/DATE: EU/1/98/066/001 - EU/1/98/066/012; 19980512 Spc suppl protection certif: 198 75 046 Filing date: 19981112 |
|
V457 | Spc granted |
Free format text: PRODUCT NAME: RIVASTIGMIN (EXELON); REGISTRATION NO/DATE: EU/1/98/066/001 - EU/1/98/066/012; 19980512 Spc suppl protection certif: 198 75 046 Filing date: 19981112 |
|
V464 | Spc expired |
Free format text: PRODUCT NAME: RIVASTIGMIN (EXELON); REGISTRATION NO/DATE: EU/1/98/066/001 - EU/1/98/066/012; 19980512 Spc suppl protection certif: 198 75 046 Filing date: 19981112 |
|
R071 | Expiry of right |
Free format text: PRODUCT NAME: RIVASTIGMIN (EXELON); NAT. REGISTRATION NO/DATE: EU/1/98/066/001-012 19980512; FIRST REGISTRATION: CH/LI 5427501-06 19970731 Spc suppl protection certif: 19875046 Filing date: 19981112 Expiry date: 20060305 Extension date: 20110304 Effective date: 20110305 |